Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
09/10/201905:00Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:REGNRegeneron Pharmaceuticals Inc
20/09/201921:22Dow Jones NewsRegeneron, Sanofi Get Positive CHMP Opinion for DupixentNASDAQ:REGNRegeneron Pharmaceuticals Inc
20/09/201920:59PR Newswire (US)The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with...NASDAQ:REGNRegeneron Pharmaceuticals Inc
20/09/201920:44PR Newswire (US)CHMP Recommends Approval of Dupixent® (dupilumab) for Severe Chronic Rhinosinusitis with Nasal PolyposisNASDAQ:REGNRegeneron Pharmaceuticals Inc
18/09/201920:59PR Newswire (US)Educational Campaign Helps Teens and Their Caregivers Tackle Everyday Challenges of Living with Moderate-to-severe Atopic Der...NASDAQ:REGNRegeneron Pharmaceuticals Inc
17/09/201921:00PR Newswire (US)Regeneron Debuts on Prestigious Dow Jones Sustainability World Index of Most Sustainable CompaniesNASDAQ:REGNRegeneron Pharmaceuticals Inc
13/09/201907:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
29/08/201908:34Dow Jones NewsU.S. Federal Judge Rules for Sanofi, Regeneron in Long-Running Patent Dispute; Amgen to AppealNASDAQ:REGNRegeneron Pharmaceuticals Inc
29/08/201906:56PR Newswire (US)U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9NASDAQ:REGNRegeneron Pharmaceuticals Inc
15/08/201923:30PR Newswire (US)Regeneron Announces Upcoming Investor Conference PresentationNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/08/201921:00PR Newswire (US)Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High...NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/08/201921:00PR Newswire (US)FDA Approves EYLEA® (aflibercept) Injection Prefilled SyringeNASDAQ:REGNRegeneron Pharmaceuticals Inc
13/08/201905:16Dow Jones NewsTwo Experimental Ebola Drugs Reduce Mortality RateNASDAQ:REGNRegeneron Pharmaceuticals Inc
13/08/201900:01PR Newswire (US)PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola DeathsNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201923:57Dow Jones NewsRegeneron, Sanofi: Dupixent Meets Main Endpoints in Children With Severe Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201923:22Dow Jones NewsRegeneron, Sanofi Get EC OK for Dupixent in Adolescents with Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201922:13Dow Jones NewsRegeneron Lowers Capital Expenditure Guidance, Changes Other Outlook MeasuresNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201921:56Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201921:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201921:27Dow Jones NewsRegeneron's Profit Falls as Expenses SpikeNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201920:30PR Newswire (US)Regeneron Reports Second Quarter 2019 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201915:04PR Newswire (US)Dupixent® (dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Der...NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/08/201914:59PR Newswire (US)Dupixent® (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
18/07/201921:30PR Newswire (US)Regeneron Announces the 2019 Winners of the Regeneron Prize for Creative InnovationNASDAQ:REGNRegeneron Pharmaceuticals Inc
10/07/201907:37Dow Jones NewsDrugmakers Rise After Trump Pricing Rule Is BlockedNASDAQ:REGNRegeneron Pharmaceuticals Inc
10/07/201903:58Dow Jones NewsDrugmakers Rise After Trump Pricing Rule Is BlockedNASDAQ:REGNRegeneron Pharmaceuticals Inc
08/07/201923:30PR Newswire (US)Regeneron to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on August 6, 201...NASDAQ:REGNRegeneron Pharmaceuticals Inc
02/07/201900:00PR Newswire (US)Libtayo® (cemiplimab) Approved for Advanced Cutaneous Squamous Cell Carcinoma in the European UnionNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/06/201922:03Dow Jones NewsCommittee Recommends Approval for Dermatitis Treatment Be ExtendedNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/06/201920:59PR Newswire (US)CHMP Recommends Approval of Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis in AdolescentsNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN